clopidogrel bisulfate tablet, film coated
proficient rx lp - clopidogrel bisulfate (unii: 08i79htp27) (clopidogrel - unii:a74586sno7) - clopidogrel 75 mg - the optimal duration of clopidogrel therapy in acs is unknown. for patients with a history of recent myocardial infarction (mi), recent stroke, or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new mi (fatal or not), and other vascular death. clopidogrel is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage. clopidogrel are contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to clopidogrel or any component of the product [see adverse reactions (6.2) ]. pregnancy category b reproduction studies performed in rats and rabbits at doses up to 500 and 300 mg/kg/day, respectively (65 and 78 times the recommended daily human dose, respectively, on a mg/m2 basis), revealed no evidence of impaired fertility or fetotoxicity due to clopidogrel. there are, however, no adequate and well-controlled studies in pregnant women. because animal repr
clopidogrel bisulfate tablet, film coated
blenheim pharmacal, inc. - clopidogrel bisulfate (unii: 08i79htp27) (clopidogrel - unii:a74586sno7) - clopidogrel 75 mg - the optimal duration of clopidogrel bisulfate therapy in acs is unknown. for patients with a history of recent myocardial infarction (mi), recent stroke, or established peripheral arterial disease, clopidogrel bisulfate has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new mi (fatal or not), and other vascular death. clopidogrel bisulfate is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage. clopidogrel bisulfate is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to clopidogrel or any component of the product [see adverse reactions (6.2)] . reproduction studies performed in rats and rabbits at doses up to 500 and 300 mg/kg/day, respectively (65 and 78 times the recommended daily human dose, respectively, on a mg/m2 basis), revealed no evidence of impaired fertility or fetotoxicity due to clopidogrel. there are, however, no adequate and well-controlled studies in pregnant women. beca
clopidogrel winthrop clopidogrel (as hydrogen sulfate) 75 mg tablet blister pack
sanofi-aventis australia pty ltd - clopidogrel hydrogen sulfate, quantity: 97.875 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; carnauba wax; mannitol; macrogol 6000; hyprolose; hydrogenated castor oil; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide red - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. acute coronary syndrome: clopidogrel winthrop is indicated in combination with aspirin for patients with: unstable angina or non-st-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). clopidogrel winthrop is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or pci, with or without stent); st-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. in this population, clopidogrel winthrop has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.
clopidogrel bisulfate tablet, film coated
aphena pharma solutions - tennessee, llc - clopidogrel bisulfate (unii: 08i79htp27) (clopidogrel - unii:a74586sno7) - clopidogrel 75 mg - in patients with established peripheral arterial disease or with a history of recent myocardial infarction (mi) or recent stroke clopidogrel bisulfate is indicated to reduce the rate of mi and stroke. clopidogrel bisulfate is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage. clopidogrel bisulfate is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to clopidogrel or any component of the product [see adverse reactions (6.2)] . pregnancy category b reproduction studies performed in rats and rabbits at doses up to 500 and 300 mg/kg/day, respectively (65 and 78 times the recommended daily human dose, respectively, on a mg/m2 basis), revealed no evidence of impaired fertility or fetotoxicity due to clopidogrel. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of a human response, clopidogrel bisulfate should be used during pregnancy only if cl
rosutrux 40mg film-coated tablets
biofarm sp. zo.o walbrzyska str 13, 60-198, poznan, poland - rosuvastatin - film-coated tablet - rosuvastatin 40 mg - lipid modifying agents
rosuvastatin galgenicum 5mg film-coated tablets
galenicum health ltd. the plaza commercial centre, level 6, suite 5, bisazza street, sliema slm 1640, malta - rosuvastatin - film-coated tablet - rosuvastatin 5 mg - lipid modifying agents
rosuvastatin galgenicum 10mg film-coated tablets
galenicum health ltd. the plaza commercial centre, level 6, suite 5, bisazza street, sliema slm 1640, malta - rosuvastatin - film-coated tablet - rosuvastatin 10 mg - lipid modifying agents
rosuvastatin galgenicum 20mg film-coated tablets
galenicum health ltd. the plaza commercial centre, level 6, suite 5, bisazza street, sliema slm 1640, malta - rosuvastatin - film-coated tablet - rosuvastatin 20 mg - lipid modifying agents
rosuvastatin galgenicum 40mg film-coated tablets
galenicum health ltd. the plaza commercial centre, level 6, suite 5, bisazza street, sliema slm 1640, malta - rosuvastatin - film-coated tablet - rosuvastatin 40 mg - lipid modifying agents
rosuvastatin galenicum 5mg film-coated tablets
galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - rosuvastatin - film-coated tablet - rosuvastatin 5 mg - lipid modifying agents